News search

    E.g., 03/04/2025
    E.g., 03/04/2025
    Dra. Hélène Girouard
    Research
    4 Aug 2024
    Dra. Hélène Girouard: “In alzheimer’s disease, high blood pressure is the main risk factor after age”

    Laboratory of Pharmacology and Physiology of the University of Montreal (Canadá)

    Sandro Da Mesquita
    Research
    6 Jul 2024
    Sandro Da Mesquita: “What really motivates me is understanding the mechanisms and the potential clinical benefits”

    Mayo Clinic College of Medicine and Science in Jacksonville

     
    Alberto Pascual
    Research
    11 Apr 2024
    Alberto Pascual: “Wanting to live forever is not the best thing for a species”
    Catarina Tristão Pereira, Enrique Lara Pezzi, Raquel Toribio Fernández, Borja Ibáñez, Valentín Fuster, Sergio Callejas, Marta Cortés Canteli, Ana Dopazo, Pilar Martín, Inés García Lunar e Irene Fernández Nueda.
    Research
    23 Jan 2024
    Circulation Research: APOE genetic variants linked to Alzheimer disease are also associated with the development of subclinical aterosclerosis

    The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis
    Rafael Yuste
    Research
    19 Dec 2023
    Rafael Yuste: “Because it accesses the centre of our mental activity, neurotechnology bypasses all of the filters that exist in the body
    Juan Domingo Gisbert
    About the CNIC
    24 Jun 2022
    Juan Domingo Gisbert: "Combining CNIC and BBRC data will allow us to answer questions of great relevance for the prevention of Alzheimer's in healthy subjects"

    Juan Domingo Gispert López, head of the Barcelonaβeta Brain Research Center and CNIC (Spanish National Centre for Cardiovascular Research) researcher
    Marta Cortés Canteli teams
    About the CNIC
    18 May 2022
    The BrightFocus Foundation grants an Alzheimer’s Disease Research Standard Award to a CNIC project

    The project will examine long-term changes in plasma biomarkers of neuronal injury, neuroinflammation, and Alzheimer's disease in participants in the PESA-CNIC-SANTANDER study who have undergone imaging studies to map brain metabolism. The goal of the project is to determine how cardiovascular risk factors during midlife impact brain function
    Marta Cortés
    About the CNIC
    6 Jul 2021
    Marta Cortés Canteli recipient of a 2021 Leonardo Grant

    This project represents a major development in the need to implement early cardiovascular intervention strategies that are capable of reducing the incidence of AD at the advanced ages in Alzheimer's disease
    3D reconstructions of superior (left) and inferior (right) brain regions, showing regions with lower metabolism associated with the presence of atherosclerotic plaques in the carotid arteries. The color code indicates the magnitude of the observation (yellow, strong association; red, lower association). Gray indicates areas showing no association with carotid plaque presence
    Research
    15 Feb 2021
    JACC: Spanish scientists uncover early links between cardiovascular risk and brain metabolism

    Among the modifiable cardiovascular risk factors showing a close association with reduced brain metabolism, the research team found that the most important is hypertension
    Irene Fernández-Nueda, Carlos Cerón y Marta Cortés-Canteli
    About the CNIC
    15 Dec 2020
    CNIC scientists coordinate a European project to develop a biomarker for the early identification of the vascular component in Alzheimer disease

    The BioClotAD project, coordinated by CNIC scientist Dr Marta Cortés Canteli, has been selected by the EU Joint Programme – Neurodegenerative Disease Research (JPND)